Skip to main content

Articles

Page 2 of 69

  1. Validated prognostic biomarkers for anti-angiogenic therapy using the anti-VEGF antibody Bevacizumab in ovarian cancer (OC) patients are still an unmet clinical need. The EGFR can contribute to cancer-associat...

    Authors: Luca Forlani, Loris De Cecco, Vittorio Simeon, Biagio Paolini, Marina Bagnoli, Sabrina Chiara Cecere, Anna Spina, Eleonora Citeroni, Eliana Bignotti, Domenica Lorusso, Laura Arenare, Daniela Russo, Carmine De Angelis, Laura Ardighieri, Giosuè Scognamiglio, Michele Del Sesto…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:83
    Content type: Research Published on:

  3. Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer treatment and revitalized the field of tumor immunology research. 3D in vitro models are emerging as powerful tools consider...

    Authors: Peiyuan Mu, Shujuan Zhou, Tao Lv, Fan Xia, Lijun Shen, Juefeng Wan, Yaqi Wang, Hui Zhang, Sanjun Cai, Junjie Peng, Guoqiang Hua and Zhen Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:81
    Content type: Review Published on:

  4. FYN is a nonreceptor tyrosine kinase that regulates diverse pathological processes. The pro-cancer role of FYN in multiple malignancies has been elucidated. However, the mechanisms that FYN promotes gastric ca...

    Authors: SanFei Peng, YuHan Yin, YiZheng Zhang, Feng Zhu, Ge Yang and Yang Fu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:80
    Content type: Research Published on:

  5. We propose a new approach for designing personalized treatment for colorectal cancer (CRC) patients, by combining ex vivo organoid efficacy testing with mathematical modeling of the results.

    Authors: George M. Ramzy, Maxim Norkin, Thibaud Koessler, Lionel Voirol, Mathieu Tihy, Dina Hany, Thomas McKee, Frédéric Ris, Nicolas Buchs, Mylène Docquier, Christian Toso, Laura Rubbia-Brandt, Gaetan Bakalli, Stéphane Guerrier, Joerg Huelsken and Patrycja Nowak-Sliwinska
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:79
    Content type: Research Published on:

  6. Aerobic glycolysis, also known as the Warburg effect, is predominantly upregulated in a variety of solid tumors, including breast cancer. We have previously reported that methylglyoxal (MG), a very reactive by...

    Authors: Gaurav Dube, Assia Tiamiou, Martin Bizet, Yasmine Boumahd, Imène Gasmi, Rebekah Crake, Justine Bellier, Marie-Julie Nokin, Emilie Calonne, Rachel Deplus, Tom Wissocq, Olivier Peulen, Vincent Castronovo, François Fuks and Akeila Bellahcène
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:78
    Content type: Research Published on:

  7. Increasing evidence has revealed the key activity of protein disulfide isomerase A4 (PDIA4) in the endoplasmic reticulum stress (ERS) response. However, the role of PDIA4 in regulating glioblastoma (GBM)-speci...

    Authors: Zewei Tu, Chong Wang, Qing Hu, Chuming Tao, Zhansheng Fang, Li Lin, Kunjian Lei, Min Luo, Yilei Sheng, Xiaoyan Long, Jingying Li, Lei Wu, Kai Huang and Xingen Zhu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:77
    Content type: Research Published on:

  8. NEO201 is a humanized IgG1 monoclonal antibody (mAb) generated against tumor-associated antigens from patients with colorectal cancer. NEO-201 binds to core 1 or extended core 1 O-glycans expressed by its targ...

    Authors: Christopher B. Cole, Maria Pia Morelli, Massimo Fantini, Markku Miettinen, Patricia Fetsch, Cody Peer, William D. Figg, Tyler Yin, Nicole Houston, Ann McCoy, Stanley Lipkowitz, Alexandra Zimmer, Jung-min Lee, Miroslava Pavelova, Erin N. Villanueva, Kathryn Trewhitt…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:76
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2023 42:102

  9. Increasing evidence suggests that FBXW7 has a high frequency of mutations in esophageal squamous cell carcinoma (ESCC). However, the function of FBXW7, especially the mutations, is not clear. This study was de...

    Authors: Yunzhi Pan, Jing Liu, Yingyin Gao, Yuqing Guo, Changxing Wang, Zhipan Liang, Meiying Wu, Yulan Qian, Yinyan Li, Jingyi Shen, Chenchen Lu and Sai Ma
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:75
    Content type: Research Published on:

  11. Cisplatin (DDP)-based chemotherapy is commonly adopted as the first-line treatment for patients with oesophageal squamous cell carcinoma (OSCC), but the high rate of drug resistance limits its clinical applica...

    Authors: Kang Fang, Mingchuang Sun, Zhuyun Leng, Yuan Chu, Ziying Zhao, Zhaoxing Li, Yunwei Zhang, Aiping Xu, Zehua Zhang, Li Zhang, Tao Chen and Meidong Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:73
    Content type: Research Published on:

  12. Although the aberrant activation of NOTCH1 pathway causes a malignant progression of renal cell carcinoma (RCC), the precise molecular mechanisms behind the potential action of pro-oncogenic NOTCH1/HES1 axis r...

    Authors: Shuangjie Liu, Lei Dou, Miao Miao, Xiaojun Man, Baojun Wei, Zhaowei Jiang, Yongze Ouyang, Toshinori Ozaki, Meng Yu and Yuyan Zhu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:72
    Content type: Research Published on:

  13. Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability, and telomere dysfunction is an important cause of acquired genomic alterations. Telomeric repeat-containing RNA (TER...

    Authors: Francesca Scionti, Giada Juli, Roberta Rocca, Nicoletta Polerà, Matteo Nadai, Katia Grillone, Daniele Caracciolo, Caterina Riillo, Emanuela Altomare, Serena Ascrizzi, Basilio Caparello, Maria Cerra, Mariamena Arbitrio, Sara N. Richter, Anna Artese, Stefano Alcaro…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:71
    Content type: Research Published on:

  14. Authors: Fei Xu, Wen-Qiang Cui, Ying Wei, Jie Cui, Jian Qiu, Ling-Li Hu, Wei-Yi Gong, Jing-Cheng Dong and Bao-Jun Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:70
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:207

  15. Metastases are the major cause of cancer-related morbidity and mortality. By the time cancer cells detach from their primary site to eventually spread to distant sites, they need to acquire the ability to surv...

    Authors: Claudia De Vitis, Anna Martina Battaglia, Matteo Pallocca, Gianluca Santamaria, Maria Chiara Mimmi, Alessandro Sacco, Francesca De Nicola, Marco Gaspari, Valentina Salvati, Francesca Ascenzi, Sara Bruschini, Antonella Esposito, Giulia Ricci, Eleonora Sperandio, Alice Massacci, Licia Elvira Prestagiacomo…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:69
    Content type: Research Published on:

  16. As a breast cancer suppressor gene, CLDN6 overexpression was found to inhibit breast cancer metastasis in our previous studies, but the specific mechanism remains unclear. This study aimed to clarify the role ...

    Authors: Yuan Dong, Qiu Jin, Minghao Sun, Da Qi, Huinan Qu, Xinqi Wang and Chengshi Quan
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:68
    Content type: Research Published on:

  17. The combination of Programmed Cell Death 1 (PD-1) and Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) blockade has dramatically improved the overall survival rate for malignant melanoma. Immune checkpoint blockers (...

    Authors: Adriana Amaro, Francesco Reggiani, Daniela Fenoglio, Rosaria Gangemi, Anna Tosi, Alessia Parodi, Barbara Banelli, Valentina Rigo, Luca Mastracci, Federica Grillo, Alessandra Cereghetti, Aizhan Tastanova, Adhideb Ghosh, Fabio Sallustio, Laura Emionite, Antonio Daga…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:67
    Content type: Research Published on:

  18. Altered microRNA profiles have been observed not only in tumour tissues but also in biofluids, where they circulate in a stable form thus representing interesting biomarker candidates. This study aimed to iden...

    Authors: Ana Belén Díaz Méndez, Andrea Sacconi, Elisa Tremante, Valentina Lulli, Valentina Caprara, Laura Rosanò, Frauke Goeman, Mariantonia Carosi, Marta Di Giuliani, Giulia Vari, Antonio Silvani, Bianca Pollo, Carlo Garufi, Sara Ramponi, Giorgia Simonetti, Emilio Ciusani…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:66
    Content type: Research Published on:

  19. Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Although most patients are initially sensitive to first-line combination chemotherapy with cisplatin and etoposide, chemotherapy dru...

    Authors: Yueqin Sun, Weitao Shen, Shulu Hu, Qiong Lyu, Qiongyao Wang, Ting Wei, Weiliang Zhu and Jian Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:65
    Content type: Research Published on:

  20. Tumor treating fields (TTF) is the latest treatment for GBM. Circular RNA (circRNA) has been demonstrated to play critical roles in tumorigenesis. However, the molecular mechanism of TTF remained largely unkno...

    Authors: Shengchao Xu, Chengke Luo, Dikang Chen, Lu Tang, Quan Cheng, Ling Chen and Zhixiong Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:64
    Content type: Research Published on:

  21. The Warburg effect is well-established to be essential for tumor progression and accounts for the poor clinical outcomes of hepatocellular carcinoma (HCC) patients. An increasing body of literature suggests th...

    Authors: Jun Zheng, Xijing Yan, Tongyu Lu, Wen Song, Yang Li, Jinliang Liang, Jiebin Zhang, Jianye Cai, Xin Sui, Jiaqi Xiao, Haitian Chen, Guihua Chen, Qi Zhang, Yubin Liu, Yang Yang, Kanghong Zheng…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:63
    Content type: Research Published on:

  22. Non-protein target drugs, especially RNA-based gene therapies for treating hereditary diseases, have been recognized worldwide. As cancer is an insurmountable challenge, no miracle drug is currently available....

    Authors: Yiwen Zhang, Lu Lu, Feifeng Song, Xiaozhou Zou, Yujia Liu, Xiaowei Zheng, Jinjun Qian, Chunyan Gu, Ping Huang and Ye Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:62
    Content type: Review Published on:

  23. We recently identified CD46 as a novel prostate cancer cell surface antigen that shows lineage independent expression in both adenocarcinoma and small cell neuroendocrine subtypes of metastatic castration resi...

    Authors: Jun Li, Tao Huang, Jun Hua, Qiong Wang, Yang Su, Ping Chen, Scott Bidlingmaier, Allan Li, Zhongqiu Xie, Anil P. Bidkar, Sui Shen, Weibin Shi, Youngho Seo, Robert R. Flavell, Daniel Gioeli, Robert Dreicer…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:61
    Content type: Research Published on:

  24. EGFR is an important signal involved in tumor growth that can induce tumor metastasis and drug resistance. Exploring targets for effective EGFR regulation is an important topic in current research and drug dev...

    Authors: Zixian Huang, Xi Rui, Chen Yi, Yongju Chen, Rui Chen, Yancan Liang, Yan Wang, Weicheng Yao, Xiaoding Xu and Zhiquan Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:60
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2023 42:104

  25. Metabolic reprogramming is one of the hallmarks of cancer. As nutrients are scarce in the tumor microenvironment (TME), tumor cells adopt multiple metabolic adaptations to meet their growth requirements. Metab...

    Authors: Shiming Tan, Yiqing Yang, Wenjuan Yang, Yaqian Han, Lisheng Huang, Ruiqian Yang, Zifan Hu, Yi Tao, Lin Liu, Yun Li, Linda Oyang, Jinguan Lin, Qiu Peng, Xianjie Jiang, Xuemeng Xu, Longzheng Xia…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:59
    Content type: Review Published on:

  26. This article has been retracted. Please see the Retraction Notice for more detail: https://10.1186/s13046-021-02081-8.

    Authors: Hongtao Liu, Qing Zhang, Yinsen Song, Yibin Hao, Yunxia Cui, Xin Zhang, Xueying Zhang, Yue Qin, Guangzhao Zhu, Feng Wang, Jinghan Dang, Shanshan Ma, Yanting Zhang, Wenna Guo, Shenglei Li, Fangxia Guan…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:58
    Content type: Retraction Note Published on:

  27. Hereditary diffuse gastric cancer (HDGC) is an autosomal dominant cancer syndrome attributed to germline CDH1 mutations that carries a high risk for early onset DGC. HDGC raises a significant health issue due to ...

    Authors: Hui Jun Lim, Lizhe Zhuang and Rebecca C. Fitzgerald
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:57
    Content type: Review Published on:

  28. Colorectal cancer (CRC) can be divided into four consensus molecular subtypes (CMS), each with distinct biological features. CMS4 is associated with epithelial-mesenchymal transition and stromal infiltration (...

    Authors: Joyce Y. Buikhuisen, Patricia M. Gomez Barila, Kate Cameron, Saskia J. E. Suijkerbuijk, Cor Lieftink, Simone di Franco, Ana Krotenberg Garcia, Rebeca Uceda Castro, Kristiaan J. Lenos, Lisanne E. Nijman, Arezo Torang, Ciro Longobardi, Joan H. de Jong, Daniëlle Dekker, Giorgio Stassi, Louis Vermeulen…
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:56
    Content type: Research Published on:

  29. Head and neck squamous cell carcinoma (HNSCC) is a heterogeneous group of tumors that affect different anatomical locations. Despite this heterogeneity, HNSCC treatment depends on the anatomical location, TNM ...

    Authors: Lola E. Navas, Elena Blanco-Alcaina, Elisa Suarez-Martinez, Eva M. Verdugo-Sivianes, Asuncion Espinosa-Sanchez, Laura Sanchez-Diaz, Eduardo Dominguez-Medina, Ceres Fernandez-Rozadilla, Angel Carracedo, Lindsay E. Wu and Amancio Carnero
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:55
    Content type: Research Published on:

  30. This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-021-02090-7.

    Authors: Guizhi Jia, Yan Wang, Chengjie Lin, Shihui Lai, Hongliang Dai, Zhiqian Wang, Luo Dai, Huizhao Su, Yanjie Song, Naiwen Zhang, Yukuan Feng and Bo Tang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:54
    Content type: Retraction Note Published on:

  31. Although the role and mechanism of neutrophils in tumors have been widely studied, the precise effects of aryl hydrocarbon receptor nuclear translocator (ARNT) on neutrophils remain unclear. In this study, we ...

    Authors: Yujing Bi, Qiuli Yang, Zhengchao Li, Yuexin Wang, Yufei Wang, Anna Jia, Zhiyuan Pan, Ruifu Yang and Guangwei Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:53
    Content type: Research Published on:

  32. Natural killer (NK) cells play a major role in body’s fighting against various types of cancers. Their infiltration in the tumor microenvironment (TME) of gastric cancer (GC) are significantly decreased, which...

    Authors: Jian-Xin Cui, Xian-Hui Xu, Tao He, Jia-Jia Liu, Tian-Yu Xie, Wen Tian and Jun-Yan Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:52
    Content type: Research Published on:

  33. Esophageal squamous cell carcinoma (ESCC) is a common gastrointestinal malignancy with poor patient prognosis. Current treatment for ESCC, including immunotherapy, is only beneficial for a small subset of pati...

    Authors: Xinghua Sui, Chunxia Chen, Xiuman Zhou, Xueyan Wen, Chao Shi, Guanyu Chen, Juan Liu, Zhuoying He, Yongjie Yao, Yin Li and Yanfeng Gao
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:51
    Content type: Research Published on:

  34. Leucocyte subpopulations in both lymphoid and myeloid lineages have a significant impact on antitumor immune response. While radiation-induced lymphopenia is being studied extensively, radiation effects on lym...

    Authors: Thao-Nguyen Pham, Julie Coupey, Serge M. Candeias, Viktoriia Ivanova, Samuel Valable and Juliette Thariat
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:50
    Content type: Review Published on:

  35. Metastasis of breast cancer grows from the local invasion to the distant colonization. Blocking the local invasion step would be promising for breast cancer treatment. Our present study demonstrated AQP1 was a...

    Authors: Zhifang Guo, Huikun Zhang, Xiaoli Liu, Yawen Zhao, Yongzi Chen, Jiaqi Jin, Caixia Guo, Ming Zhang, Feng Gu and Yongjie Ma
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:49
    Content type: Research Published on:

  36. Circular RNAs (circRNAs) have important regulatory functions in cancer, but the role of circRNAs in the tumor microenvironment (TME) remains unclear. Moreover, we also explore the effects of si-circRNAs loaded...

    Authors: Boxuan Zhou, Zhaohong Mo, Guie Lai, Xiaohong Chen, Ruixi Li, Runxin Wu, Jia Zhu and Fang Zheng
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:48
    Content type: Research Published on:

  37. Authors: Hui Li, Tian Lan, Lin Xu, Hailing Liu, Jinju Wang, Jiaxin Li, Xiangzheng Chen, Jiwei Huang, Xuefeng Li, Kefei Yuan, Yong Zeng and Hong Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:47
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2020 39:128

  38. Exosome is crucial mediator and play an important role in tumor angiogenesis. Tip cell formation is a prerequisite for persistent tumor angiogenesis which causes tumor metastasis. However, the functions and un...

    Authors: Chen Chen, Yang Liu, Lin Liu, Chaohua Si, Yanxin Xu, Xiaoke Wu, Chengzeng Wang, Zhenqiang Sun and Qiaozhen Kang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:46
    Content type: Research Published on:

  39. Bone is the most common site of metastasis of prostate cancer (PCa). PCa invasion leads to a disruption of osteogenic-osteolytic balance and causes abnormal bone formation. The interaction between PCa and bone...

    Authors: Depei Kong, Chen Ye, Chenxi Zhang, Xiaochen Sun, Fubo Wang, Rui Chen, Guangan Xiao, Shipeng He, Jianrong Xu, Xiwu Rao, Jianzhong Ai, Xu Gao, Hong Li and Li Su
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:45
    Content type: Research Published on:

  40. Advanced gastric cancer (GC) is a lethal malignancy, harboring recurrent alterations in cell cycle pathway, especially the CDKN2A-CDK4/CDK6/CCND1 axis. However, monotherapy of CDK4/6 inhibitors has shown limit...

    Authors: Mei Feng, Hao Xu, Wenyuan Zhou and Yisheng Pan
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:44
    Content type: Research Published on:

  41. This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s13046-020-01606-x.

    Authors: Guoliang Sun, Hui Zhou, Ke Chen, Jin Zeng, Yangjun Zhang, Libin Yan, Weimin Yao, Junhui Hu, Tao Wang, Jinchun Xing, Kefeng Xiao, Lily Wu, Zhangqun Ye and Hua Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:43
    Content type: Retraction Note Published on:

  42. Clear cell renal cell carcinoma (ccRCC), with its hallmark phenotype of high cytosolic lipid content, is considered a metabolic cancer. Despite the implication of this lipid-rich phenotype in ccRCC tumorigenes...

    Authors: Tin Tin Manh Nguyen, Thi Ha Nguyen, Han Sun Kim, Thien T. P. Dao, Yechan Moon, Munjun Seo, Sunmi Kang, Van-Hieu Mai, Yong Jin An, Cho-Rok Jung, Jin-Mo Kim and Sunghyouk Park
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:42
    Content type: Research Published on:

  43. The response rate to immunotherapy in patients with bladder cancer (BCa) remains relatively low. Considering the stable existence and important functions in tumour metabolism, the role of circRNAs in regulatin...

    Authors: Jiancheng Lv, Kai Li, Hao Yu, Jie Han, Juntao Zhuang, Ruixi Yu, Yidong Cheng, Qiang Song, Kexin Bai, Qiang Cao, Haiwei Yang, Xiao Yang and Qiang Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:41
    Content type: Research Published on:

  44. Lymph node and distant metastasis contribute to poor outcomes in patients with oral squamous cell carcinoma (OSCC). The mechanisms regulating cancer migration and invasion play a key role in OSCC.

    Authors: Sheng-Yen Hsiao, Shang-Mei Weng, Jenn-Ren Hsiao, Yi-Ying Wu, Jia-En Wu, Chia-Hao Tung, Wan-Lin Shen, Shu-Fang Sun, Wen-Tsung Huang, Cheng-Yao Lin, Shang-Hung Chen, Tse-Ming Hong, Yuh-Ling Chen and Jang-Yang Chang
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:40
    Content type: Research Published on:

  45. Recurrence of retinoblastoma (RB) following chemoreduction is common and is often managed with local (intra-arterial/intravitreal) chemotherapy. However, some tumors are resistant to even local administration ...

    Authors: Atthapol Srimongkol, Natanan Laosillapacharoen, Duangporn Saengwimol, Vijender Chaitankar, Duangnate Rojanaporn, Thanastha Thanomchard, Suparerk Borwornpinyo, Suradej Hongeng and Rossukon Kaewkhaw
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:39
    Content type: Research Published on:

  46. Hepatic inflammation is a common initiator of liver diseases and considered as the primary driver of hepatocellular carcinoma (HCC). However, the precise mechanism of inflammation-induced HCC development and i...

    Authors: Yunzhi Liu, Qishan Xu, Fan Deng, Zhuojun Zheng, Jialiang Luo, Ping Wang, Jia Zhou, Xiao Lu, Liyun Zhang, Zhengliang Chen, Qifan Zhang, Qingyun Chen and Daming Zuo
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:38
    Content type: Research Published on:

  47. A pharmacogenomic platform using patient-derived cells (PDCs) was established to identify the underlying resistance mechanisms and tailored treatment for patients with advanced or refractory lung cancer.

    Authors: Namhee Yu, Mihwa Hwang, Youngjoo Lee, Bo Ram Song, Eun Hye Kang, Hanna Sim, Beung-Chul Ahn, Kum Hui Hwang, Jihyun Kim, Sehwa Hong, Sunshin Kim, Charny Park and Ji-Youn Han
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:37
    Content type: Research Published on:

  48. Genetic background plays an important role in the occurrence and development of gastric cancer (GC). With the application of genome-wide association study (GWAS), an increasing number of tumor susceptibility g...

    Authors: Yuqi Chen, Wenying Yan, Kexi Yang, Yiting Qian, Yanjun Chen, Ruoqin Wang, Jinghan Zhu, Yuxin He, Hongya Wu, Guangbo Zhang, Tongguo Shi and Weichang Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:36
    Content type: Research Published on:

  49. Breast cancer is the most frequently diagnosed cancer and a common cause of cancer-related death in women. It is well recognized that obesity is associated with an enhanced risk of more aggressive breast cance...

    Authors: Andreas Ritter, Nina-Naomi Kreis, Susanne Roth, Alexandra Friemel, Babek Kahn Safdar, Samira Catharina Hoock, Julia Maria Wildner, Roman Allert, Frank Louwen, Christine Solbach and Juping Yuan
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:35
    Content type: Research Published on:

  50. Metabolic reprogramming is a hallmark of various cancers. Targeting metabolic processes is a very attractive treatment for cancer. Renal cell carcinoma (RCC) is a type of metabolic disease, and the lipidomic p...

    Authors: Xintian Chen, Hongmei Yong, Miaolei Chen, Chuyin Deng, Pengfei Wang, Sufang Chu, Minle Li, Pingfu Hou, Junnian Zheng, Zhongwei Li and Jin Bai
    Citation: Journal of Experimental & Clinical Cancer Research 2023 42:34
    Content type: Research Published on:

Annual Journal Metrics

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us